MMS
Maximus, Inc.
MMS has the edge over RKLB overall, supported by stronger valuation and lower modeled downside.
RKLB
Rocket Lab USA, Inc.
RKLB offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
MMS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Unavailable |
MMS's profitability and cash flow are currently healthy, and its revenue is stable. There isn't enough data to rate its balance sheet.
RKLB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
MMS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 7.4x | $64.87 | — |
| Current | 9.7x | $64.87 | — |
| Cheap | 15x | $97.91 | +51% |
| Fair | 19x | $128 | +98% |
| Expensive | 26x | $176 | +171% |
Historical ranges are pointers, not guarantees.
MMS's PE is in its cheap range at 9.7x. If earnings grow as analysts expect, today's price would be 7.4x next year's earnings.
RKLB PE Valuation
RKLB has no meaningful PE right now: it lost money over the past year.
MMS Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect MMS's earnings to grow and its profitability to improve, with its revenue holding steady.
RKLB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
RKLB has the edge over MMS on the outlook, with more favorable revenue expectations.
MMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $8.77 | +31% |
| Q2 2026 | $6.72 | +24% |
| Q1 2026 | $6.63 | +32% |
| Q4 2025 | $6.52 | +41% |
| Q3 2025 | $5.51 | +10% |
| Q2 2025 | $5.42 | +14% |
| Q1 2025 | $5.02 | +32% |
| Q4 2024 | $4.64 | +54% |
| Q3 2024 | $4.99 | +90% |
MMS has the edge over RKLB on earnings quality, reporting a profit while its opponent remains loss making.
RKLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.36 | +$0.03 |
| Q2 2026 | -$0.27 | +$0.19 |
| Q1 2026 | -$0.32 | +$0.09 |
| Q4 2025 | -$0.37 | +$0.01 |
| Q3 2025 | -$0.39 | -$0.02 |
| Q2 2025 | -$0.46 | -$0.11 |
| Q1 2025 | -$0.41 | -$0.04 |
| Q4 2024 | -$0.38 | $0.00 |
RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.
MMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $1.3B | -5.1% |
| Q1 2026 | $1.3B | -4.1% |
| Q4 2025 | $1.3B | -4.1% |
| Q3 2025 | $1.3B | +0.2% |
| Q2 2025 | $1.3B | +2.5% |
| Q1 2025 | $1.4B | +1% |
| Q4 2024 | $1.4B | +5.7% |
| Q3 2024 | $1.3B | +4.4% |
MMS's revenue grew through 2023 and has held roughly level since: $1.3B last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 13% | +0.3 points |
| Q1 2026 | 11% | +0.1 points |
| Q4 2025 | 11% | +4.7 points |
| Q3 2025 | 9.3% | +0.8 points |
| Q2 2025 | 12% | +1.5 points |
| Q1 2025 | 11% | +1.8 points |
| Q4 2024 | 6.2% | -1.9 points |
| Q3 2024 | 8.5% | +0.6 points |
MMS has the edge over RKLB on profitability, with a higher operating margin.
RKLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.8M | +73% |
| Q2 2026 | $234.1M | +62% |
| Q1 2026 | $200.3M | +63% |
| Q4 2025 | $179.7M | +36% |
| Q3 2025 | $155.1M | +48% |
| Q2 2025 | $144.5M | +36% |
| Q1 2025 | $122.6M | +32% |
| Q4 2024 | $132.4M | +121% |
RKLB has the edge over MMS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -30% | +8.5 points |
| Q2 2026 | -25% | +17 points |
| Q1 2026 | -28% | +20 points |
| Q4 2025 | -28% | +11 points |
| Q3 2025 | -38% | +12 points |
| Q2 2025 | -41% | -0.5 points |
| Q1 2025 | -48% | -1.9 points |
| Q4 2024 | -39% | +41 points |
RKLB's operating margin was −30% last quarter, up 8.5 points from the same quarter a year ago.
MMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$137M | +$61.2M |
| Q1 2026 | $179M | +602% |
| Q4 2025 | -$250.7M | -$147.7M |
| Q3 2025 | $641.8M | +387% |
| Q2 2025 | -$198.2M | -220% |
| Q1 2025 | $25.5M | -76% |
| Q4 2024 | -$103M | -$102.3M |
| Q3 2024 | $131.9M | +17% |
MMS has the edge over RKLB on cash generation, producing positive trailing cash flow while its opponent burns cash.
RKLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$23.9M | +$45.5M |
| Q2 2026 | -$110.1M | -$54.8M |
| Q1 2026 | -$77.4M | +$5.5M |
| Q4 2025 | -$114.2M | -$90.2M |
| Q3 2025 | -$69.4M | -$27.5M |
| Q2 2025 | -$55.3M | -$26.9M |
| Q1 2025 | -$82.9M | -$61.1M |
| Q4 2024 | -$23.9M | +$28.7M |
RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.
MMS Net Leverage
RKLB Net Leverage
RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
MMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 55.9 | Neutral |
| Stochastic | 78.9 | Neutral |
MMS's weekly RSI is 56 (neutral) and its Stochastic is 79 (neutral).
RKLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 27.6 | Neutral |
RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).
MMS PE vs Industrials Sector
| Metric | MMS | Sector median | Relative |
|---|---|---|---|
| PE | 9.7x | 24x | 60% below |
| PE % | 7 | 58 | 51 pts below |
MMS is trading at 9.7x earnings, a 60% discount to the Industrials sector's median of 24x.
RKLB PE vs Industrials Sector
RKLB has no meaningful PE right now: it lost money over the past year.
MMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $60.4 | 7.4% above |
| 20 week MA | $58.8 | 10% above |
| 50 week MA | $67.7 | 4.2% below |
| 100 week MA | $72.0 | 9.9% below |
| 200 week MA | $77.3 | 16% below |
MMS has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 16% below its 200-week average.
RKLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.4 | 4.3% above |
| 20 week MA | $68.1 | 5.9% below |
| 50 week MA | $77.6 | 17% below |
| 100 week MA | $56.5 | 13% above |
| 200 week MA | $31.4 | 104% above |
RKLB has the edge over MMS on trend strength, trading above more of its moving averages.
MMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $74.3 | $72.8 | -2% |
| 2021 | $72.8 | $78.1 | +7.2% |
| 2022 | $78.1 | $73.6 | -5.7% |
| 2023 | $73.6 | $83.9 | +14% |
| 2024 | $83.9 | $72.9 | -13% |
| 2025 | $72.9 | $86.9 | +19% |
| 2026 YTD | $86.9 | $64.9 | -25% |
MMS has finished lower in three of the last six years. It's down 25% so far in 2026.
RKLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.82 | $10.3 | +4.9% |
| 2021 | $10.3 | $12.0 | +17% |
| 2022 | $12.0 | $3.77 | -69% |
| 2023 | $3.77 | $5.53 | +47% |
| 2024 | $5.53 | $27.2 | +392% |
| 2025 | $27.2 | $70.7 | +160% |
| 2026 YTD | $70.7 | $64.1 | -9.3% |
RKLB has the edge over MMS on returns for 2026, with the stronger performance.